Conferences - Results from #760

Viewing 761-780 of 11869 articles

APCCC 2024: Alternative PSMA Ligands for Diagnostics and Treatment – Are They Interchangeable?

APCCC 2024: PARP Inhibition Dissected – in Which DNA Repair Gene Alterations Works Which PARP Inhibitor?

APCCC 2024: How Do We Maximize Use of Radiotherapy for Prostate Cancer in Africa

APCCC 2024: The Best Use of PARP Inhibitors in mCRPC

APCCC 2024: Lancet Commission on Prostate Cancer– the Forthcoming Surge in Prostate Cancer Raises Very Different Issues to the Ones We Face Today

APCCC 2024: Ideal Sequence After ADT plus ARPI plus Docetaxel for mHSPC

APCCC 2024: How to Manage Side Effects of PARP Inhibitors?

APCCC 2024: Cardiovascular Complications in Advanced Prostate Cancer – How to Prevent Them and How to Monitor Patients?

APCCC 2024: Debate: How to Best Manage a Fit Patient with High-Risk Localised and Locally Advanced Prostate Cancer? How to Select Patients for Adjuvant Therapy After Radical Prostatectomy and How to Treat Them?

APCCC 2024: PSMA Radioligand Therapy – State of the Art

APCCC 2024: How Do Non-DDR Genomic Alterations Influence Management of Patients with Advanced Prostate Cancer?

APCCC 2024: Who Should Undergo Germline Testing?

APCCC 2024: How to Treat Men with Aggressive Variant or Neuroendocrine Prostate Cancer

APCCC 2024: Ideal Sequence after ADT Alone or ADT plus ARPI for mHSPC

APCCC 2024: When to Do Tumor Genomic Profiling in Advanced Prostate Cancer and What?

APCCC 2024: Future Changes in the Setting of mHSPC

APCCC 2024: How to Manage Patients with Low-Volume on Conventional and High-Volume on Next Generation Imaging

APCCC 2024: Management of Frail Patients with mHSPC

APCCC 2024: Management of Patients with mHSPC and Early Progression on Combination Therapy

APCCC 2024: Genomic Classifiers and Artificial Intelligence as Predictors for Treatment Benefit

34
35
36
37
38
39
40
41
42
43